Cargando…

Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations

Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CF is a multi-organ disease that involves the lungs, pancreas, sweat glands, digestive and reproductive syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara-Reyna, Samuel, Holbrook, Jonathan, Jarosz-Griffiths, Heledd H., Peckham, Daniel, McDermott, Michael F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599191/
https://www.ncbi.nlm.nih.gov/pubmed/32367193
http://dx.doi.org/10.1007/s00018-020-03540-9
_version_ 1783602818445213696
author Lara-Reyna, Samuel
Holbrook, Jonathan
Jarosz-Griffiths, Heledd H.
Peckham, Daniel
McDermott, Michael F.
author_facet Lara-Reyna, Samuel
Holbrook, Jonathan
Jarosz-Griffiths, Heledd H.
Peckham, Daniel
McDermott, Michael F.
author_sort Lara-Reyna, Samuel
collection PubMed
description Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CF is a multi-organ disease that involves the lungs, pancreas, sweat glands, digestive and reproductive systems and several other tissues. This debilitating condition is associated with recurrent lower respiratory tract bacterial and viral infections, as well as inflammatory complications that may eventually lead to pulmonary failure. Immune cells play a crucial role in protecting the organs against opportunistic infections and also in the regulation of tissue homeostasis. Innate immune cells are generally affected by CFTR mutations in patients with CF, leading to dysregulation of several cellular signalling pathways that are in continuous use by these cells to elicit a proper immune response. There is substantial evidence to show that airway epithelial cells, neutrophils, monocytes and macrophages all contribute to the pathogenesis of CF, underlying the importance of the CFTR in innate immune responses. The goal of this review is to put into context the important role of the CFTR in different innate immune cells and how CFTR dysfunction contributes to the pathogenesis of CF, highlighting several signalling pathways that may be dysregulated in cells with CFTR mutations.
format Online
Article
Text
id pubmed-7599191
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-75991912020-11-10 Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations Lara-Reyna, Samuel Holbrook, Jonathan Jarosz-Griffiths, Heledd H. Peckham, Daniel McDermott, Michael F. Cell Mol Life Sci Review Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CF is a multi-organ disease that involves the lungs, pancreas, sweat glands, digestive and reproductive systems and several other tissues. This debilitating condition is associated with recurrent lower respiratory tract bacterial and viral infections, as well as inflammatory complications that may eventually lead to pulmonary failure. Immune cells play a crucial role in protecting the organs against opportunistic infections and also in the regulation of tissue homeostasis. Innate immune cells are generally affected by CFTR mutations in patients with CF, leading to dysregulation of several cellular signalling pathways that are in continuous use by these cells to elicit a proper immune response. There is substantial evidence to show that airway epithelial cells, neutrophils, monocytes and macrophages all contribute to the pathogenesis of CF, underlying the importance of the CFTR in innate immune responses. The goal of this review is to put into context the important role of the CFTR in different innate immune cells and how CFTR dysfunction contributes to the pathogenesis of CF, highlighting several signalling pathways that may be dysregulated in cells with CFTR mutations. Springer International Publishing 2020-05-04 2020 /pmc/articles/PMC7599191/ /pubmed/32367193 http://dx.doi.org/10.1007/s00018-020-03540-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Lara-Reyna, Samuel
Holbrook, Jonathan
Jarosz-Griffiths, Heledd H.
Peckham, Daniel
McDermott, Michael F.
Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
title Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
title_full Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
title_fullStr Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
title_full_unstemmed Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
title_short Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
title_sort dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599191/
https://www.ncbi.nlm.nih.gov/pubmed/32367193
http://dx.doi.org/10.1007/s00018-020-03540-9
work_keys_str_mv AT larareynasamuel dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations
AT holbrookjonathan dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations
AT jaroszgriffithsheleddh dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations
AT peckhamdaniel dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations
AT mcdermottmichaelf dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations